AstraZeneca has admitted in court documents that its COVID-19 vaccine could cause a rare but deadly blood-clotting condition, potentially exposing the UK pharmaceutical giant to tens of millions in Read this story
AstraZeneca has admitted in court documents that its COVID-19 vaccine could cause a rare but deadly blood-clotting condition, potentially exposing the UK pharmaceutical giant to tens of millions in Read this story
More from New York Post | World News blood COVID vaccine lawsuits pharmaceuticals united kingdom article Vaccine AstraZeneca